Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis

Carbon, Maren, Kane, John M., Leucht, Stefan, Correll, Christoph U.·2018·World Psychiatry
DOI 10.1002/wps.20579

Cited by (213)

Items 201–213 of 213

  1. SwapIII: Clarifying the role of D2 receptor occupancy in psychosis and movement disorders
    Mushde Shakir, Peter N. van Harten, Adriaan W. Hoogendoorn, Anne E. Willems, Tessa L.L. Stout, Diederik E. Tenback · 2026 · Psychiatry Research Communications
  2. COREIA IATROGÊNICA POR INTERAÇÃO MEDICAMENTOSA EM PACIENTES COM EPILEPSIA E DEFICIÊNCIA INTELECTUAL: UMA REVISÃO NARRATIVA
    João Pedro Manduca Ferreira, Luiza Azzi Vaz de Campos, Ledismar José da Silva · 2026 · RECIMA21 - Revista Científica Multidisciplinar
  3. Availability and future perspectives of psychopharmaceuticals in the Czech-Slovak context: what is and isn't available, and what could be
    Štefan Artim · 2026 · Psychiatrie pro praxi
  4. Perspectives
    John D. Cahill, Keith Gallagher · 2026 · Cambridge University Press eBooks
  5. A Patient-Empowering Approach to Side Effects of Psychiatric Medications
    Keith Gallagher, John D. Cahill · 2026 · Cambridge University Press eBooks
  6. Reconciling Divergence of Perspective in Psychiatric Prescribing
    Keith Gallagher, David Stark · 2026 · Cambridge University Press eBooks
  7. COBENFY - A NEW ANTIPSYCHOTIC DRUG
    Gabriela Majchrowicz, Mikołaj Jońca, Natasza Kurys, Szymon Litke, Katarzyna Gołacka, Aleksandra Lorent, Weronika Piekarska · 2026 · International Journal of Innovative Technologies in Social Science
  8. Clinical and neurobiological correlates of tardive dyskinesia in schizophrenia spectrum disorders and mood disorders
    Dilsa Cemre Akkoc Altinok, Sebastian Volkmer, Stefan Fritze, Geva A. Brandt, Lana Wölfl, Jacqueline Kukovic, Amanda Bellanti, Anastasia Pavlidou, Sofie von Känel, Stéphanie Lefebvre et al. · 2026 · Schizophrenia
  9. Antipsychotic Use in Pediatric Posttraumatic Stress Disorder and Trauma-Related Disorders
    Ayman Saleh, Brandon Trojanowski, Fadi Hamati, Joshua D. Feder · 2026 · Child and Adolescent Psychiatric Clinics of North America
  10. Tardive Dyskinesia in Patients Receiving Continuous Versus Intermittent Oral Metoclopramide: A Retrospective Real World Study
    Pierantonio Russo, Ramaa Nathan, Michael Camilleri · 2026 · Neurogastroenterology & Motility
  11. A Case Report: Successful Management of Mixed Tardive Syndrome With Combination Pharmacotherapy in a 19‐Year‐Old Female With Schizophrenia
    Wenmao Yang, Rui Li, Zhi‐quan Cui, Huaning Wang, Qing-Rong Tan, Zhengwu Peng · 2026 · Clinical Case Reports
  12. Closing the neurology–psychiatry gap in tardive dyskinesia care in the Asia–Pacific region: consensus recommendations for educational initiatives to improve prevention, recognition, and shared care
    Roongroj Bhidayasiri, Yun-Cheng Wu, Chavit Tunvirachaisakul, Jong-Min Kim, Taro Kishi, Tianhong Zhang, Jung Kyung Hong, Hirohisa Watanabe · 2026 · Research Square
  13. Closing the neurology–psychiatry gap in tardive dyskinesia care in Asia: expert recommendations for an educational roadmap to improve prevention, recognition, and shared care
    Roongroj Bhidayasiri, Yun-Cheng Wu, Chavit Tunvirachaisakul, Jong-Min Kim, Taro Kishi, Tianhong Zhang, Jung Kyung Hong, Hirohisa Watanabe · 2026 · Journal of Neural Transmission